Source comparison
Best Tesamorelin + Ipamorelin Blend Dosage Fat Loss 2026: Protocol Comparison
This table compares the three most common dosing protocols used in fat loss research, showing how frequency and timing affect visceral adipose tissue reduction over 16 weeks. Standard Clinical 2mg 300mcg 5 days/week Pre-bed (fasted) 12–15% Evidence-supported b
This comparison does not assign a generated winner or score.
- This table compares the three most common dosing protocols used in fat loss research, showing how frequency and timing affect visceral adipose tissue reduction over 16 weeks.
- Standard Clinical
- 2mg
- 300mcg
- 5 days/week
- Pre-bed (fasted)
- 12–15%
- Evidence-supported baseline. Aligns with Phase 3 trial data and preserves receptor sensitivity
- High-Frequency
- 7 days/week
- 9–11%
- Initial gains plateau after week 8 due to receptor desensitization. Not recommended beyond 12 weeks
- Split-Dose
- 1mg (AM) + 1mg (PM)
- 150mcg (AM) + 150mcg (PM)
- Morning + evening
- 7–9%
- Disrupts natural pulsatility. Morning dose competes with cortisol awakening response
- Low-Dose Maintenance
- 1mg
- 200mcg
- 3 days/week
- 4–6%
- Insufficient for initial fat loss but viable for maintenance after goal VAT reached